Mupirocin and bacitracin are not the same medication. They are two different antibiotics with different chemical structures, different strengths, and different roles in treating skin infections. The most practical difference: bacitracin is available over the counter, while mupirocin requires a prescription. That distinction exists for good reason, as the two drugs differ in potency, bacterial coverage, and how they’re used clinically.
How They Work Differently
Bacitracin is a polypeptide antibiotic that kills bacteria by disrupting their cell walls. It’s selectively active against gram-positive bacteria, the broad category that includes staph and strep species. It works well enough for everyday scrapes and minor cuts, which is why it’s been a medicine cabinet staple for decades.
Mupirocin takes a completely different approach. Originally derived from a soil bacterium called Pseudomonas fluorescens, it works by blocking a specific enzyme bacteria need to build proteins. Without that enzyme, the bacteria can’t grow or reproduce. This mechanism gives mupirocin a narrower but more clinically powerful target range: it’s effective against most staph bacteria (including MRSA), and most strep species, though it doesn’t work against a group called enterococci.
The MRSA Factor
The single biggest clinical difference between these two antibiotics is MRSA coverage. MRSA, or methicillin-resistant Staphylococcus aureus, is a staph strain that resists many common antibiotics. Mupirocin remains one of the go-to topical treatments for MRSA skin infections and is the standard choice for clearing MRSA from the nasal passages, a common hiding spot for the bacteria. A Canadian health technology review found grade-A evidence that mupirocin is more effective than other agents at eliminating nasal staph carriage, and that this decolonization protects against staph infections in both dialysis patients and intensive care patients.
Bacitracin has no established role in MRSA treatment or decolonization. If you’re dealing with a confirmed or suspected MRSA infection, bacitracin from the drugstore isn’t a substitute for prescription mupirocin.
What Each One Is Used For
Infectious disease guidelines from the IDSA recommend mupirocin as a first-line treatment for impetigo, a contagious bacterial skin infection common in children. The recommended course is twice daily for five days. For people with recurrent staph skin abscesses, guidelines suggest a decolonization regimen that includes intranasal mupirocin alongside antiseptic body washes and laundering personal items like towels and sheets.
Bacitracin, by contrast, doesn’t appear in these clinical guidelines for skin and soft tissue infections. Its primary role is over-the-counter wound care: applying a thin layer to minor cuts, scrapes, and small burns to help prevent infection. It’s a preventive measure for clean, superficial wounds rather than a treatment for established infections.
Formulations and Availability
Bacitracin comes as a topical ointment at a standard concentration of 500 units per gram. You’ll find it at any pharmacy without a prescription, often combined with other antibiotics in products like Neosporin (which adds neomycin and polymyxin B to the mix).
Mupirocin is available as a 2% ointment or a 2% cream, and both require a prescription. The ointment formulation is typically used for skin infections, while the cream can be preferable for certain areas. A separate nasal ointment formulation exists specifically for decolonization.
Allergy and Skin Reactions
One important safety consideration favors mupirocin. Bacitracin is a surprisingly common cause of allergic contact dermatitis, and the problem has gotten worse over time. The rate of bacitracin allergy climbed from about 1.5% of tested patients during 1985 to 1989, up to roughly 8 to 12% during 2011 to 2015. Among children with allergic contact dermatitis, bacitracin is the causative agent in about 6% of cases. Reactions can range from redness and itching to a more unusual purpuric (bruise-like) rash.
Mupirocin causes allergic reactions far less frequently. If you’ve ever had a rash or irritation from bacitracin or Neosporin, mupirocin is often the alternative your doctor will prescribe instead.
Resistance Concerns With Mupirocin
Because mupirocin is more potent and used in hospital settings for MRSA decolonization, resistance is a growing concern. A recent meta-analysis found a resistance rate of about 7.6% among staph isolates overall, rising to roughly 13.8% among MRSA isolates specifically. North and South America have higher resistance rates compared to the rest of the world, likely driven by routine use in healthcare facilities for nasal MRSA eradication.
Two types of resistance exist. High-level resistance, which essentially makes mupirocin useless against that strain, spreads between bacteria on mobile genetic elements called plasmids. Low-level resistance, caused by smaller genetic changes, may still allow the drug to work at higher concentrations. This is one reason mupirocin remains prescription-only: controlling access helps slow resistance.
Which One You Actually Need
For a minor cut or scrape on otherwise healthy skin, over-the-counter bacitracin or plain petroleum jelly is reasonable wound care. Studies have shown that keeping a wound moist and covered matters more than which topical antibiotic you use for clean, superficial injuries.
Mupirocin is the better choice when you’re dealing with an actual bacterial skin infection like impetigo, a wound that shows signs of infection (spreading redness, warmth, pus), MRSA concerns, or when your doctor recommends nasal decolonization. It’s also the standard alternative if you’re allergic to bacitracin. Since it requires a prescription, your provider can evaluate whether it’s the right fit based on the type and severity of your infection.